THE JOHN R. LAMONTAGNE LECTURE SERIES
2023 LaMontagne Lecture - March 21, 2023, 3:00 p.m.
Peter J. Hotez, M.D., Ph.D. will be the speaker for the 2023 LaMontagne Symposium to be held March 21, 2023, 3:00 p.m. at the Connally Ballroom in the Etter-Harbin Alumni Center on the UT Campus. The title of his lecture is Global Vaccinations and "The Anti-Poverty Vaccines": Science vs. Anti-Science.
Dr. Hotez is Dean of the National School of Tropical Medicine, Professor of Pediatrics and Molecular Virology & Microbiology, and University Professor at Baylor College of Medicine. He is Co-director of the Texas Children’s Center for Vaccine Development (CVD) and holds the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. He is a Fellow in Disease and Poverty at the James A Baker III Institute for Public Policy, Senior Fellow at the Scowcroft Institute of International Affairs at Texas A&M University, Faculty Fellow with the Hagler Institute for Advanced Studies at Texas A&M University, and Health Policy Scholar in the Baylor Center for Medical Ethics and Health Policy.
Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development, championing access to vaccines globally and in the United States. As co-director of the Texas Children’s CVD, he leads a team and product development partnership for developing new vaccines for hookworm infection, schistosomiasis, leishmaniasis, Chagas disease, and SARS/MERS/SARS-2 coronaviruses, diseases affecting hundreds of millions of children and adults worldwide.
In December 2021, Dr. Hotez led efforts at the Texas Children’s Center for Vaccine Development to develop a low-cost recombinant protein COVID vaccine for global health, resulting in emergency use authorization in India. In 2022, Hotez and his colleague Dr. Maria Elena Bottazzi were nominated for the Nobel Peace Prize for “their work to develop and distribute a low-cost COVID-19 vaccine to people of the world without patent limitation.”
Dr. Hotez has authored more than 600 original papers and is the author of five single-author books, including Forgotten People, Forgotten Diseases (ASM Press); Blue Marble Health: An Innovative Plan to Fight Diseases of the Poor amid Wealth (Johns Hopkins University Press); Vaccines Did Not Cause Rachel’s Autism (Johns Hopkins University Press); and Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-science (Johns Hopkins University Press). Dr. Hotez appears frequently on television (including BBC, CNN, Fox News, and MSNBC), radio, and in newspaper interviews (including the New York Times, USA Today, Washington Post, and Wall Street Journal).
For more information on Dr. Hotez and his work, please go to peterhotez.org.
LCID Researchers in the News
Contact Us
LaMontagne Center for Infectious Disease
University of Texas at Austin
2506 Speedway, A5000
Austin, TX 78712
Email
Donate to LCID
LATEST NEWS | COLLEGE OF NATURAL SCIENCES
TWITTER FEEDS
LCID at UT
-
Congratulations to LCID Faculty Member Jason S. McLellan @McLellan_Lab, the 2023 recipient of both the @WelchFoundation Norman Hackerman Award and @theNASciences Award in Molecular Biology, recognizing his pioneering work in structure-based vaccine design!
t.co/Ka4Q2pume2 t.co/YsR7rww2VI
-
SAVE THE DATE: LCID announces the 2023 John Ring LaMontagne Annual Keynote Lecture and Symposium, featuring Dr. Peter J. Hotez. The Symposium will be held March 21, 2023 at 3 pm on the UT Austin campus. For more information: t.co/6KN9w8ROMi t.co/Th0fIYh0BD
Center for Disease Control
- #COVID19 deaths are not being overcounted in the United States. However, there has been some confusion in understanding how covid death data is collected and reported, esp. when compared with hospitalization data. Read more from CDC's Deb Houry in @wapo. t.co/dj3w4aLS3e
-
CDC’s Drug-Free Communities Support Program is the nation’s leading effort to mobilize communities to prevent youth substance use.
Find out how your community can get involved: t.co/D6UkffVU4P t.co/X18zLLSeAW
World Health Organization
- Day 3 WHO Executive Board #EB152 will start at 10h00 CET. More info & follow the discussion live t.co/MrRdcZLFsN